Literature DB >> 17959911

Granulomatous renal masses following intravesical bacillus Calmette Guérin therapy: the central unaffected calyx sign.

A T Senés1, L Badet, D Lyonnet, O Rouvière.   

Abstract

A 67-year-old man with a history of melanoma, treated surgically 7 years before, was referred for vomiting and right flank pain after three intravesical instillations of bacillus Calmette-Guérin (BCG) for superficial bladder cancer. A CT scan showed a mass on the right kidney, with a normal calyx in its centre. Percutaneous biopsy, obtained because of melanoma history, showed granulomatous reaction caused by BCG infection. The renal mass disappeared after 9 months of anti-tuberculous treatment. The presence of an unaffected calyx in the centre of the renal mass is an interesting finding for both teaching purposes--it clearly illustrates the pathogeny of the disease, with the bacillus invading the renal parenchyma through the papilla--and diagnostic purposes--a malignant tumour is likely to displace or destroy neighbouring calyces rather than leaving them unaffected. However, the diagnostic value of this sign remains to be determined by further research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959911     DOI: 10.1259/bjr/42250860

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  7 in total

1.  BCG-related renal granulomas managed conservatively: A case series.

Authors:  Talal Al-Qaoud; Fadi Brimo; Armen G Aprikian; Sero Andonian
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

2.  Infection as a Differential Diagnosis of Solid Retroperitoneal Masses: A Case Series and Review of the Literature.

Authors:  Georgia Levidou; Tilman Klein; Kerstin Schaefer-Eckart; Clemens Huettenbrink; Panagiota Manava
Journal:  Cureus       Date:  2022-05-01

3.  Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder.

Authors:  Suresh Bhat; Yateesh Srinivasa; Fredrick Paul
Journal:  Indian J Urol       Date:  2015 Jul-Sep

Review 4.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Renal Tuberculosis Following Intravesical Bacillus Calmette-Guérin (BCG) Immunotherapy for the Treatment of Bladder Cancer.

Authors:  Senad Bajramovic; Jasmin Alic; Edna Skopljak; Adisa Chikha; Sanela Vesnic; Velda Smajilbegovic; Damir Aganovic
Journal:  Med Arch       Date:  2020-04

6.  Biopsy-diagnosed renal granuloma after intravesical bacillus Calmette-Guérin therapy for bladder carcinoma: a case series and review of the literature.

Authors:  Keiichi Narita; Hirotaka Akita; Eiji Kikuchi; Tadaki Nakahara; Shigeo Okuda; Seishi Nakatsuka; Mototsugu Oya; Masahiro Jinzaki
Journal:  BJR Case Rep       Date:  2019-11-15

7.  Renal Granulomatosis Post Intravesical Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer.

Authors:  Karen Tran-Harding; Rashmi T Nair; Halemane Ganesh
Journal:  J Clin Imaging Sci       Date:  2018-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.